Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.45
+0.50 (1.43%)
Apr 17, 2026, 2:00 PM CST
Market Cap2.59B +100.3%
Revenue (ttm)708.38M +36.9%
Net Income-39.43M
EPS-0.54
Shares Out72.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,340,379
Average Volume858,869
Open34.90
Previous Close34.95
Day's Range34.60 - 36.85
52-Week Range16.90 - 35.50
Beta0.05
RSI90.44
Earnings DateApr 24, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2025, Genomics BioSci & Tech.'s revenue was 708.38 million, an increase of 46.74% compared to the previous year's 482.75 million. Losses were -39.43 million, -82.33% less than in 2024.

Financial Statements